Gastroesophageal reflux disease as a cause of death is increasing: Analysis of fatal cases after medical and surgical treatment

American Journal of Gastroenterology

Volumn 102, Issue 2, 2007, Pages 246-253

  Rantanen, Tuomo K ^a   Sihvo, Eero I T ^b   Räsänen, Jari V ^b   Salo, Jarmo A ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTACID AGENT; ANTICOAGULANT AGENT; CORTISONE; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROKINETIC AGENT; PROTON PUMP INHIBITOR; SUCRALFATE;

ADOLESCENT; ADULT; AGED; ANTIREFLUX OPERATION; ARTICLE; ASPIRATION PNEUMONIA; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENDOSCOPIC SURGERY; ESOPHAGITIS; ESOPHAGUS HEMORRHAGE; ESOPHAGUS RESECTION; ESOPHAGUS RUPTURE; ESOPHAGUS STRICTURE; FEMALE; GASTRECTOMY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; STOMACH FUNDOPLICATION; SYMPTOM; TREATMENT FAILURE; TREATMENT OUTCOME; ULCER PERFORATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENZYME INHIBITORS; ESOPHAGECTOMY; FEMALE; FINLAND; FOLLOW-UP STUDIES; FUNDOPLICATION; GASTRECTOMY; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; INFANT; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROTON PUMPS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33846556613     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.01021.x     Document Type: Article

References (43)

1. Locke GR 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted county, Minnesota. Gastroenterology 1997;112:1448-56.
2. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995;27:67-70.
3. Fennerty MB. The continuum of GERD complications. Clev Clin J Med 2003;70:S33-50.
4. Kieser C. Untersuchungen über die tödlichen Komplikationen von Hiatushernien. Gastroenterologia 1967;107:328-36.
5. Brunnen PL, Karmody AM, Needham CD. Severe peptic esophagitis. Gut 1969;10:831-7.
6. Panos MZ, Walt RP, Stevenson C, et al. Rising death rate from non-malignant disease of the oesophagus (NMOD) in England and Wales. Gut 1995;36:488-91.
7. Rantanen T, Salo JA. Gastroesophageal reflux disease as a cause of death: Analysis of fatal cases under conservative treatment. Scand J Gastroenterol 1999;34:229-33.
8. Rantanen TK, Salo JA, Sipponen JT. Fatal and life-threatening complications in antireflux surgery: Analysis of 5,502 operations. Br J Surg 1999;86:1573-7.
9. Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990;335:205-8.
10. Savary M, Miller G. Handbook and atlas of endoscopy. Solothurn, Switzerland: Verlag Gassmann, 1983.
11. Rasilainen J, Salmela R. Treatment periods of surgical procedures in Finland during 1987-2000. National Research and Development Centre for Welfare and Health. Statistical Notices 1987-2000. Annual reports; Helsinki 1987-2000.
12. Finnish Statistics on Medicines 1987-2000, National Agency for Medicines and Social Insurance Institution, Helsinki 1987-2000.
13. Shaheen N, Provenzale D. The epidemiology of gastroesophageal reflux disease. Am J Med Sci 2003;326:264-73.
14. Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from multiethnic Asian country. Am J Gastroenterol 2005;100:1923-8.
15. Laine L, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: A post hoc analysis of eight double blind prospective studies. Am J Gastroenterol 2002;97:2992-7.
16. Heller SR, Fellows IW, Ogilvie AL, et al. Non-steroidal anti-inflammatory drugs and benign oesophageal stricture. BMJ 1982;285:167-8.
17. Kikendall JW, Friedman AC, Oye-Wol MA, et al. Pill-induced esophageal injury. Case reports and review of the medical literature. Dig Dis Sci 1983;28:174-82.
18. Wilkins WE, Ridley MG, Pozniak AL. Benign stricture of the oesophagus: Role of non-steroidal anti-inflammatory drugs. Gut 1984;25:478-80.
19. Lanas A, Hirschowitz BI. Significant role of aspirin use in patients with esophagitis. J Clin Gastroenterol 1991;13:622-7.
20. Viljakka M, Luostarinen M, Isolauri J. Incidence of antireflux surgery in Finland 1988-1993. Influence of proton-pump inhibitors and laparoscopic technique. Scand J Gastroenterol 1997;32:415-8.
21. McMahon RL, Mercer CD. National trends in gastroesophageal reflux surgery. Can J Surg 2000;43:48-52.
22. Sandbu R, Haglund U, Arvidsson D, et al. Antireflux surgery in Sweden, 1987-1997: A decade of change. Scand J Gastroenterol 2000;35:345-8.
23. Finlayson SR, Laycock WS, Birkmeyer JD. National trends in utilization and outcomes of antireflux surgery. Surg Endosc 2003;17:864-7.
24. Räihä I, Impivaara O, Seppälä M, et al. Determinants of symptoms suggestive of gastroesophageal reflux disease in the elderly. Scand J Gastroenterol 1993;28:1011-4.
25. Richter JE. Gastroesophageal reflux disease in the older patient: Presentation, treatment, and complications. Am J Gastroenterol 2000;95:368-73.
26. Hurwitz A. Gastric acidity in older adults. JAMA 1997;278:659-65.
27. Lasch H, Castell DO, Castell JA. Evidence for diminished visceral pain with aging: Studies using graded intraesophageal balloon distension. Am J Physiol 1997;272:G1-3.
28. Mold JW, Reed LE, Davis AB, et al. Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol 1991;86:965-70.
29. Zhu H, Pace F, Sangaletti O, et al. Features of symptomatic gastroesophageal reflux in elderly patients. Scand J Gastroenterol 1993;28:235-8.
30. El-Serag HB, Sonnenberg A. Associations between different forms of gastro-oesophageal reflux disease. Gut 1997;41:594-9.
31. Escourrou J, Deprez P, Saggioro A, et al. Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis. Aliment Pharmacol Ther 1999;13:1481-91.
32. Pilotto A, Leandro G, Franceschi M. Ageing and acid-related diseases group. Aliment Pharmacol 2003;17:1399-406.
33. Rockall TA, Logan RFA, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996;38:316-21.
34. Zimmerman J, Shohat V, Tsvang E, et al. Esophagitis is a major cause of upper gastrointestinal hemorrhage in the elderly. Scand J Gastroenterol 1997;32:906-9.
35. Bohmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, et al. The prevalence of gastroesophageal reflux disease in institutionalized intellectually disabled individuals. Am J Gastroenterol 1999;94:804-10.
36. Orchard JL, Stramat J, Wolfgang M, et al. Upper gastrointestinal bleeding in institutionalized mentally retarded adults. Primary role of esophagitis. Arch Fam Med 1995;4:30-3.
37. Bor S, Bor-Caymaz C, Tobey NA, et al. Esophageal exposure to ethanol increases risk of acid damage in rabbit esophagus. Dig Dis Sci 1999;44:290-300.
38. Labenz J, Jaspersen D, Kulig M, et al. Risk factors for erosive esophagitis: A multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 2004;99:1652-6.
39. deManzoni G, Catalano F, Festini M, et al. Esophageal nonvariceal hemorrhage: A clinical and epidemiological study. G Chir 2002;23:199-204.
40. Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest 2003;124:328-36.
41. Oh E, Weintraub N, Dhanani S. Can we prevent aspiration pneumonia in the nursing home? J Am Med Dir Assoc 2004;5:174-9.
42. Takamizawa S, Tsugawa C, Nishijima E, et al. Laryngotracheal separation for intractable aspiration pneumonia in neurologically impaired children: Experience with 11 cases. J Pediatr Surg 2003;38:975-7.
43. Bozkurt M, Tutuncuoglu S, Serdaroglu G, et al. Gastroesophageal reflux in children with cerebral palsy: Efficacy of cicapride. J Chil Neurol 2004;19:973-6.